Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Philadelphia Displays Many Facets of the Healthcare Debate

David S. Pisetsky, MD, PhD  |  Issue: January 2010  |  January 1, 2010

In the debate about healthcare, the voices of the people have been very quiet, likely because they lack the resources to make them louder and because they have few options for forging any common viewpoint. I cannot help but think that our citizens want decent and affordable care and do not particularly care whether it is provided by the public or private sector. For that matter, I think that most providers do not really worry about the structure of healthcare as long as it is fair and equitable and they would be more than happy if the discussion turned from so-called unnecessary care to unnecessary bureaucracy.

About one thing I am sure. The people in this country are great supporters of medical research and they want to make investments of the kind of science that, in rheumatology, has produced methotrexate, TNF blockers, bisphosphonates, and the myriad new agents for inflammation or pain on the horizon. Our people are deeply committed to improvements in care as embodied in the progress since the founding of the ACR during the dark days of The Depression.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

About one thing I am sure. The people in this country are great supporters of medical research and they want to make investments of the kind of science that, in rheumatology, has produced methotrexate, TNF blockers, bisphosphonates, and the myriad new agents for inflammation or pain on the horizon.

A Different Kind of Research Support

On Sunday morning after the opening ceremony, I got up early to attend a lecture on the pathogenesis of rheumatoid arthritis by my good friend and collaborator, Steffen Gay, MD. Alas, blue laws are no longer in force, at least when it comes to scientific meetings. Although I think that Sunday morning should be a time for slumber, crossword puzzles, or church, the pressure to gain new knowledge and hours of continuing education credit have nullified the concept of a day of rest. Steffen gave a great lecture, although as soon as it was over, I rushed back to my hotel room to catch some needed shuteye.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

On my way down Market Street to get to the Loews Hotel where I was staying, I noticed coming toward me a procession of people who were oddly dressed. Certainly, there were many people in the City of Brotherly Love who looked differently than the usual Durhamite, but these people, mostly women, seemed to be in costume. Many were wearing large pink foam rabbit ears that said “Energizer.” At that point, the weather was sill miserable, trying to rival that of the EULAR meeting in terms of the number of inches of cold rain that fell. On the walkers, plastic anoraks and raincoats were in full force, rather than long, black leather coats that the Philadelphians seem to like.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyOpinionProfessional TopicsResearch RheumRheuminationsSpeak Out Rheum Tagged with:AC&RAdvocacyHealthcareHealthcare ReformLegislationPatientsResearch

Related Articles

    Do RA Patients in Clinical Trials for Biologics Represent the Average?

    October 4, 2016

    It’s estimated that a majority of patients with rheumatoid arthritis (RA) have been exposed to biologic treatments. However, the randomized controlled trials demonstrating the safety and efficacy of these biologic agents have strict participant eligibility requirements. New research has examined the requirements of 30 trials for biologics and applied those standards to two large clinical cohorts. The result: A majority of these RA patients did not satisfy the criteria…

    University of Nebraska Division of Rheumatology and Immunology Makes Education, Clinical Research Top Priorities

    August 13, 2017

    When it was created in 1982, the Division of Rheumatology and Immunology at the University of Nebraska Medical Center comprised one-and-a-half rheumatologists: its founder, Lynell W. Klassen, MD, MACR, and Gerald Moore, MD, who later received formal training at the NIH and now serves as senior associate dean for academic affairs. Thirty-five years later, the…

    Doused in Denmark

    August 1, 2009

    EULAR captured the complex picture of rheumatology’s future

    Is It Cold in Here? Working in Cold Environments Linked to RA

    February 14, 2018

    Novel research has linked cold environments—with snow, ice and overall frigid conditions—to an increased risk of developing rheumatoid arthritis. This research has many rheumatologists eager for more research that could aid patients and further the understanding of the disease…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences